Pharsight

Drugs that contain Guanfacine Hydrochloride

1. Intuniv patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6811794 TAKEDA PHARMS USA Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
Jul, 2022

(1 year, 7 months ago)

US6811794

(Pediatric)

TAKEDA PHARMS USA Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
Jan, 2023

(1 year, 1 month ago)

Market Authorisation Date: 02 September, 2009

Treatment: Treatment of attention-deficit hyperactivity disorder

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of INTUNIV before it's drug patent expiration?
More Information on Dosage

INTUNIV family patents

Family Patents